Acquisition Chelsea Therapeutics International, Ltd by H. Lundbeck A/S May Not Be in Shareholders’ Best Interests

Acquisition Chelsea Therapeutics International, Ltd by H. Lundbeck A/S May Not Be in Shareholders’ Best Interests

[PR Newswire] – SAN DIEGO and CHARLOTTE, N.C., May 12, 2014 /PRNewswire/ — Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Chelsea Therapeutics International, Ltd (CHTP) by the private equity firm H. Lund more

View todays social media effects on CHTP

View the latest stocks trending across Twitter. Click to view dashboard

See who Chelsea is hiring next, click here to view

Share this post